A nationwide survey of hepatitis C services provided by drug treatment programs

Journal of Substance Abuse Treatment

Volumn 22, Issue 2, 2002, Pages 55-62

  Strauss, Shiela M ^a   Falkin, Gregory P ^a   Vassilev, Zdravko ^a   Des Jarlais, Don C ^b   Astone, Janetta ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Disease prevention; Drug treatment programs; HCV services; Telephone survey; Treatment modality

Indexed keywords

ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; DRUG USE; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HEPATITIS C; HIGH RISK PATIENT; HUMAN; INTERVIEW; OUTPATIENT; PATIENT EDUCATION; PRIORITY JOURNAL; PROPHYLAXIS; QUESTIONNAIRE; RESIDENCY EDUCATION; SAMPLE; SUBSTANCE ABUSE; TELEPHONE; UNITED STATES;

AMBULATORY CARE; COUNSELING; DELIVERY OF HEALTH CARE; HEALTH CARE SURVEYS; HEPATITIS C; HEPATITIS C ANTIBODIES; HOSPITALIZATION; HUMANS; NATIONAL HEALTH PROGRAMS; PATIENT EDUCATION; REFERRAL AND CONSULTATION; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 0036202472     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0740-5472(01)00213-6     Document Type: Article

References (43)

1. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis
2. Drug addiction and treatment careers among clients in the Drug Abuse Treatment Outcome Study (DATOS)
3. Assessing the need, use, and developments in mental health/substance abuse care
4. Hepatitis C virus in intravenous drug users
5. Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment
6. Patient and program attributes related to treatment process indicators in DATOS
7. AIDS and HIV infection- implications for drug abuse treatment
8. Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers
9. Organizational factors related to AIDS/HIV education in outpatient substance abuse treatment units
10. Current management of infectious complications in the injecting drug user
11. Hepatitis C virus infection in a sexually active inner city population. The potential for heterosexual transmission
12. An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units
13. Emerging infectious diseases and the injection of illicit psychoactive drugs
14. Survey of hepatitis B and C in an addiction treatment unit
15. Risk of human immunodeficiency virus infection among pregnant crack cocaine users in a rural community
16. Treatment structure and program services in the Drug Abuse Treatment Outcome Study (DATOS)
17. Organizational correlates of access to primary care and mental health services in drug abuse treatment units
18. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users
19. Delivery of HIV risk-reduction services in drug treatment programs
20. Syringe exchange and risk of infection with hepatitis B and C viruses
21. Role of drug-abuse treatment in limiting the spread of AIDS
22. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS)
23. Hepatitis C: public strategies
24. Perspectives on linkage of primary health care and substance abuse treatment
25. Current and future treatment of hepatitis C
26. Drug abuse treatment as AIDS prevention
27. HIV prevention with drug-using populations-current status and future prospects: introduction and overview
28. Hepatitis C virus infection in a male homosexual cohort: risk factor analysis
29. Recreational drugs and sexual behavior in the Chicago MACS/CCS cohort of homosexually active men. Chicago Multicenter AIDS Cohort Study (MACS)/Coping and Change Study
30. Drug-user treatment programs in a large metropolitan area
31. Services research outcome study: explanation of treatment effectiveness, using individual-level and programmatic variables
32. The natural history of viral hepatitis, type C
33. Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program
34. Drug abuse treatment as an HIV prevention strategy: a review
35. Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment
36. Correlates of hepatitis C virus infections among injection drug users
37. Providing medical care to methadone clinic patients: referral vs. on-site care
38. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland
39. National survey of hepatitis testing and vaccination services provided by drug services in England and Wales
40. Background to crack cocaine addiction and HIV high-risk behavior: the next epidemic
41. Seroepidemiology of viral infections among intravenous drug users in northern California
42. Peginterferon alfa-2a in patients with chronic hepatitis C
43. Hepatitis C: education and counseling issues